Pathway Financial Advisers LLC Sells 68,113 Shares of Exelon Co. (NASDAQ:EXC)

Pathway Financial Advisers LLC trimmed its position in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 97.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,727 shares of the company's stock after selling 68,113 shares during the period. Pathway Financial Advisers LLC's holdings in Exelon were worth $65,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. State Street Corp raised its position in shares of Exelon by 3.7% during the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company's stock worth $2,439,862,000 after buying an additional 2,156,259 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Exelon by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company's stock worth $1,048,823,000 after purchasing an additional 403,542 shares during the last quarter. FMR LLC grew its stake in shares of Exelon by 18.7% in the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company's stock worth $477,782,000 after purchasing an additional 1,858,502 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Exelon by 1.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company's stock worth $363,626,000 after purchasing an additional 160,313 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Exelon by 2.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 6,446,408 shares of the company's stock worth $261,402,000 after purchasing an additional 123,466 shares during the last quarter. 80.92% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several research firms have recently weighed in on EXC. Scotiabank lifted their target price on shares of Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research report on Thursday. Barclays reduced their target price on shares of Exelon from $44.00 to $42.00 and set an "overweight" rating for the company in a research note on Wednesday, January 22nd. Evercore ISI upgraded shares of Exelon from an "in-line" rating to an "outperform" rating and upped their target price for the company from $43.00 to $44.00 in a research note on Tuesday, January 21st. Guggenheim raised shares of Exelon from a "neutral" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, Morgan Stanley reduced their price target on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating on the stock in a research report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $43.38.

Insider Buying and Selling at Exelon

In other news, EVP Colette D. Honorable sold 1,463 shares of Exelon stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the sale, the executive vice president now owns 2,271 shares of the company's stock, valued at approximately $92,134.47. The trade was a 39.18 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.10% of the company's stock.

Exelon Stock Down 0.3 %

Shares of EXC traded down $0.12 on Monday, reaching $42.85. The company's stock had a trading volume of 8,592,975 shares, compared to its average volume of 6,340,731. The company has a current ratio of 1.09, a quick ratio of 0.97 and a debt-to-equity ratio of 1.66. Exelon Co. has a twelve month low of $34.01 and a twelve month high of $43.45. The stock has a market capitalization of $43.06 billion, a PE ratio of 17.63, a PEG ratio of 2.74 and a beta of 0.56. The firm has a fifty day moving average of $38.93 and a 200-day moving average of $38.97.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.60% and a return on equity of 9.47%. During the same quarter last year, the company posted $0.60 earnings per share. Equities analysts predict that Exelon Co. will post 2.46 EPS for the current year.

Exelon Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 3.73%. This is an increase from Exelon's previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Monday, February 24th. Exelon's dividend payout ratio (DPR) is presently 62.55%.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.